These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3126651)

  • 1. Abnormal platelet von Willebrand factor interaction in patients with TTP.
    Rock G; Tittley P; Taylor JR
    Am J Hematol; 1988 Mar; 27(3):179-83. PubMed ID: 3126651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombotic thrombocytopenia induced in dogs and pigs. The role of plasma and platelet vWF in animal models of thrombotic thrombocytopenic purpura.
    Sanders WE; Reddick RL; Nichols TC; Brinkhous KM; Read MS
    Arterioscler Thromb Vasc Biol; 1995 Jun; 15(6):793-800. PubMed ID: 7773736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet reactive conformation and multimeric pattern of von Willebrand factor in acquired thrombotic thrombocytopenic purpura during acute disease and remission.
    Lotta LA; Lombardi R; Mariani M; Lancellotti S; De Cristofaro R; Hollestelle MJ; Canciani MT; Mannucci PM; Peyvandi F
    J Thromb Haemost; 2011 Sep; 9(9):1744-51. PubMed ID: 21726405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura.
    Tsai HM; Rice L; Sarode R; Chow TW; Moake JL
    Ann Intern Med; 2000 May; 132(10):794-9. PubMed ID: 10819702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Willebrand factor abnormalities and endothelial cell perturbation in a patient with acute thrombotic thrombocytopenic purpura.
    Moake JL; Rudy CK; Troll JH; Weinstein MJ; Colannino NM; Hong SL; Koutcher JA; Melaragno AJ; Manner CE
    Am J Med Sci; 1986 Jan; 291(1):47-50. PubMed ID: 3079954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Moake JL; McPherson PD
    Am J Med; 1989 Sep; 87(3N):9N-15N. PubMed ID: 2486537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal interaction between platelets and von Willebrand factor in patients with TTP.
    Rock G; Tittley P; Taylor RJ
    Prog Clin Biol Res; 1990; 337():129-33. PubMed ID: 2162061
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy.
    Byrnes JJ; Moake JL
    Clin Haematol; 1986 May; 15(2):413-42. PubMed ID: 3524932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of fresh-frozen plasma and its cryosupernatant fraction on von Willebrand factor multimeric forms in chronic relapsing thrombotic thrombocytopenic purpura.
    Moake JL; Byrnes JJ; Troll JH; Rudy CK; Hong SL; Weinstein MJ; Colannino NM
    Blood; 1985 May; 65(5):1232-6. PubMed ID: 3873262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased platelet retention in familial recurrent thrombotic thrombocytopenic purpura.
    Karpman D; Holmberg L; Jirgård L; Lethagen S
    Kidney Int; 1996 Jan; 49(1):190-9. PubMed ID: 8770967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. von Willebrand factor mediates increased platelet retention in recurrent thrombotic thrombocytopenic purpura.
    Karpman D; Lethagen S; Kristoffersson A; Isaksson C; Holmberg L
    Thromb Haemost; 1997 Dec; 78(6):1456-62. PubMed ID: 9423794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The changes in von Willebrand factor multimer in a course of thrombotic thrombocytopenic purpura].
    Saitoh M; Wada H; Tanigawa M; Tamaki S; Masuya M; Minami N; Deguchi K; Shirakawa S; Tatewaki W; Takahashi H
    Rinsho Ketsueki; 1991 Sep; 32(9):1006-8. PubMed ID: 1942536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura.
    Moore JC; Murphy WG; Kelton JG
    Br J Haematol; 1990 Apr; 74(4):457-64. PubMed ID: 2346725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M; Lämmle B
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multimeric composition of von Willebrand factor in thrombotic thrombocytopenic purpura. Japanese TTP Study Group].
    Tatewaki W
    Nihon Rinsho; 1993 Jan; 51(1):146-50. PubMed ID: 8433508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of von Willebrand factor (vWF) in thrombotic thrombocytopenic purpura (TTP) and the hemolytic-uremic syndrome (HUS).
    Moake JL
    Prog Clin Biol Res; 1990; 337():135-40. PubMed ID: 2191307
    [No Abstract]   [Full Text] [Related]  

  • 17. Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura.
    Furlan M; Robles R; Morselli B; Sandoz P; Lämmle B
    Thromb Haemost; 1999 Jan; 81(1):8-13. PubMed ID: 10348715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAMTS13 content in plasma-derived factor VIII/von Willebrand factor concentrates.
    Peyvandi F; Mannucci PM; Valsecchi C; Pontiggia S; Farina C; Retzios AD
    Am J Hematol; 2013 Oct; 88(10):895-8. PubMed ID: 23813910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombosis and von Willebrand Factor.
    Shahidi M
    Adv Exp Med Biol; 2017; 906():285-306. PubMed ID: 27628010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
    Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
    N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.